Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
Susan B. Bressler, MD, FASRS
Annual Meeting Talks
2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Geeta A. Lalwani, MD
Comparing Outcomes of Standard and Reduced-Fluence Photodynamic Therapy in the Treatment of Polypoidal Choroidal Vasculopathy
Colin S Tan, MBBS, MMed (Ophth), FRCSEd (Ophth)
Category: Complications of Anterior Segment Surgery